Final results from the NuProtect study demonstrating efficacy of Nuwiq (simoctocog alfa) in previously untreated patients (PUPs) presented at ASH 2019
LACHEN, Switzerland--(BUSINESS WIRE)--Dec 10, 2019--
LACHEN, Switzerland--(BUSINESS WIRE)--Dec 10, 2019--